Sanofi
7,340 posts
Sanofi
@sanofi
An R&D driven, AI-powered biopharma company committed to improving lives and delivering compelling growth. Terms for interactions: bit.ly/sanofi-terms
With the approval from the @EU_Commission, our subcutaneous multiple myeloma (MM) therapy is now authorized across all existing IV indications for MM in the EU. Read more: sanofi.com/en/media-room/…
- Our Q1 2026 results are now available. See the press release for more details: spkl.io/6014AfHOC #SanofiResults $SAN $SNY
- The @US_FDA has approved our medicine for certain children aged 2-11 years with uncontrolled chronic spontaneous urticaria (CSU). ➡️ Read more: sanofi.com/en/media-room/… CC: @Regeneron
- The @US_FDA has approved a treatment for eligible young children with #Type1Diabetes. With this approval, we hope to better support these young T1D patients and their families. Learn more: spkl.io/6015A47zl
- #NEWS: COMPARE study presented at #ESCMIDGlobal2026: head-to-head tolerability comparison of a protein-based and an mRNA COVID-19 vaccine Read our press release: spkl.io/6011A4Znl
- The @EU_Commission has approved our medicine in the EU for the treatment of chronic spontaneous urticaria (CSU) in certain children aged 2 to 11 years. More information here ➡️: sanofi.com/en/media-room/… CC: @Regeneron
